**Core Concept**
The MDR gene, also known as multidrug resistance protein 1 (MDR1), encodes a transmembrane glycoprotein that functions as an efflux pump, transporting a wide range of chemotherapeutic agents out of cancer cells, thereby conferring resistance to these drugs.

**Why the Correct Answer is Right**
The MDR protein, a product of the MDR gene, utilizes ATP hydrolysis to transport chemotherapeutic agents, such as doxorubicin and vinblastine, across the plasma membrane, thereby reducing intracellular concentrations and rendering the cancer cells resistant to these drugs. This efflux mechanism is mediated by the MDR protein's interaction with ATP-binding cassette (ABC) transporters, which undergo conformational changes upon ATP binding, facilitating the transport of chemotherapeutic agents out of the cell.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as the MDR gene does not encode a protein that is involved in DNA repair mechanisms.
**Option B:** This option is incorrect as the MDR protein is not a receptor that binds chemotherapeutic agents, but rather an efflux pump that transports these agents out of the cell.
**Option C:** This option is incorrect as the MDR gene is not involved in the regulation of apoptosis (programmed cell death).

**Clinical Pearl / High-Yield Fact**
The MDR gene is a classic example of a mechanism of resistance to chemotherapy, and understanding its role in conferring resistance to chemotherapeutic agents is crucial for developing strategies to overcome this resistance and improve cancer treatment outcomes.

**Correct Answer: D. The MDR protein acts as an efflux pump to transport chemotherapeutic agents out of cancer cells.**